Additionally, in keeping with knowledge from other tumors (13, 32), the narrowed TR and IGH repertoires in the TME of CD8-predominant AITL may indicate downregulated anti-tumor immunity via inadequate immunosurveillance of tumor T-cell neoantigens. The gene discussed is CD8A; the disease is neoplasm.